Medical Device and Diagnostic Industry (MD+DI)

Strategies for Implementing AI-Powered Medical Devices

Successful implementation requires modern healthcare infrastructure, including reliable electricity, high-speed internet ...
The Manila Times

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company,' 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, ...